According to a report from the NY Post on January 7th, the Biden administration is advancing a plan to reduce the nicotine content in cigarettes during the final stages of Biden's presidency. Critics argue that this could potentially lead to increased smoking among Americans and fuel organized crime groups.
The Food and Drug Administration (FDA) announced last week that they have just completed a regulatory review of the proposed rule "Standards for Tobacco Products with Reduced Nicotine Content" in the Office of Management and Budget's ROCIS system, showing that the review was completed on January 3rd.
According to reports, the plan claims to aim at reducing the addictiveness of cigarettes for casual users. However, opponents believe that this change could lead to existing smokers using more cigarettes to compensate for the reduced nicotine content, and could potentially open up opportunities for black market sales of standard nicotine content cigarettes.
Rich Marianos, former Assistant Director of the Bureau of Alcohol, Tobacco, Firearms and Explosives, stated in an interview with Fox News that the ban is essentially a "gift" to organized crime groups, which will only lead to increased smoking and exacerbate street violence among Americans.
It is currently unclear whether the FDA will release proposed rules regarding the regulation before Biden leaves office on January 20. The plan was announced for 2022, with formal proposed rules expected in 2023, but the reasons for the delay are unknown. Similarly, progress on the FDA's ban on mint-flavored cigarettes has also been slow.
Once the draft rules are proposed, they will enter the public notice and comment phase, where supporters and opponents will present their arguments before a final decision is made. This process is likely to impact the government of President-elect Donald Trump, with the final decision being controlled by relevant officials nominated by the Republican Party, such as Health and Human Services Secretary nominee Robert F. Kennedy Jr. and FDA Commissioner nominee Marty Makary.
FDA director Robert Califf stated in 2022 that the program will help current smokers as well as future potential smokers. Many cigarette users have already switched to other nicotine delivery options considered to be lower risk, such as e-cigarettes and smokeless tobacco.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
